News Sentiment

EPRX sentiment intelligence

Eupraxia Pharmaceuticals Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 23 relevant articles
Exchange TOR Canada
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 9.46 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

86/100 classification confidence.

Company focus 23

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-0.7% over one week, +12.0% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Positive

Canaccord Genuity Initiates Coverage on Jazz Pharmaceuticals With Buy Rating, $290 Price Target

Market Reaction

Balanced read

55/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 86/100 classification
One-week reaction -0.7% Price digesting
Trend fit Trend inactive 12.0% over four weeks
Fair value 45.7% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 7
Neutral 16
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 23
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 9
Wealth Awesome 3
GlobeNewswire 3
MT Newswires 2
dars.gov.et 2
TradingKey 1
Market source 1
simplywall.st 1

Event Lens

What the news is about

Classified themes
Market update 17
Earnings 3
Analyst action 2
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-23 of 23